Recombinant human granulocyte colony-stimulating factor (rhG-CSF) is now undergoing
clinical trials. We investigated the effects of rhG-CSF on the function of neutrophils in vivo in …

We studied the effects of recombinant human granulocyte colony-stimulating factor (rG-CSF)
on neutrophil functions in vitro using neutrophils isolated from the venous blood of normal …

We recently showed that recombinant human granulocyte‐colony stimulating factor (rhG‐
CSF) maintained the viability of human neutrophils in incubation for up to 72 hours …

Granulocyte‐macrophage colony‐stimulating factor (GM‐CSF)(250 μg/m2) was
administered subcutaneously to 7 normal volunteers for up to 14 days to study its effects on …

BACKGROUND AND OBJECTIVE: Recombinant human granulocyte colony-stimulating
factor (rhG-CSF) is currently used for treatment of various types of neutropenia, treatment of …

Granulocyte colony‐stimulating factor (G‐CSF) has been shown to stimulate human
neutrophil functions, both in vitro and in vivo. We examined the effects of G‐CSF …

The pharmacokinetics of recombinant human granulocyte-colony stimulating factor (rhG-
CSF)(produced by Kirin Brewery Co., Ltd.) in sera was studied after iv and sc administration …

抄録 Pharmacological effect after intravenous (iv) or subcutaneous (sc) administration of
human recombinant granulocyte colony stimulating factor (rhG-CSF) was evaluated by using …

Granulocyte colony‐stimulating factor (G‐CSF) is a haematopoietic growth factor required
for the proliferation and differentiation of haematopoietic precursors of neutrophil …

Recombinant granulocyte colony-stimulating factor (G-CSF) was administered to healthy
young (n= 32) and elderly (n= 19) volunteers (0 microgram/d, 30 microgram/d, or 300 …